Your browser doesn't support javascript.
loading
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.
Bilich, Tatjana; Nelde, Annika; Bichmann, Leon; Roerden, Malte; Salih, Helmut R; Kowalewski, Daniel J; Schuster, Heiko; Tsou, Chih-Chiang; Marcu, Ana; Neidert, Marian C; Lübke, Maren; Rieth, Jonas; Schemionek, Mirle; Brümmendorf, Tim H; Vucinic, Vladan; Niederwieser, Dietger; Bauer, Jens; Märklin, Melanie; Peper, Janet K; Klein, Reinhild; Kohlbacher, Oliver; Kanz, Lothar; Rammensee, Hans-Georg; Stevanovic, Stefan; Walz, Juliane S.
Afiliação
  • Bilich T; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Nelde A; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Bichmann L; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Roerden M; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Salih HR; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Kowalewski DJ; Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany.
  • Schuster H; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Tsou CC; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Marcu A; Clinical Cooperation Unit Translational Immunology, German Cancer Consortium, German Cancer Research Center (DKFZ) partner site Tübingen, Germany.
  • Neidert MC; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Lübke M; Immatics Biotechnologies, Tübingen, Germany.
  • Rieth J; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Schemionek M; Immatics Biotechnologies, Tübingen, Germany.
  • Brümmendorf TH; Immatics US, Houston, Texas.
  • Vucinic V; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Niederwieser D; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Bauer J; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Märklin M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Peper JK; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Klein R; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Kohlbacher O; Department of Hematology and Oncology, University Hospital Leipzig, Leipzig, Germany.
  • Kanz L; Department of Hematology and Oncology, University Hospital Leipzig, Leipzig, Germany.
  • Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Stevanovic S; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Walz JS; Clinical Cooperation Unit Translational Immunology, German Cancer Consortium, German Cancer Research Center (DKFZ) partner site Tübingen, Germany.
Blood ; 133(6): 550-565, 2019 02 07.
Article em En | MEDLINE | ID: mdl-30530751
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Linfócitos T CD4-Positivos / Proteínas de Fusão bcr-abl / Epitopos de Linfócito T / Antígenos HLA / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Linfócitos T CD4-Positivos / Proteínas de Fusão bcr-abl / Epitopos de Linfócito T / Antígenos HLA / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos